6- hydroxy- 4- (1- hydroxy- 1- methylethyl)- 1- cyclohexene- 1- ethanol

structure given in first source; mucoregulatory drug; RN given refers to the (4R-trans)-isomer; RN for cpd without isomeric designation not avail 9/90

Also Known As:

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Obstructive Lung Diseases (Obstructive Lung Disease) 05/01/1992 - "The results obtained point out the potential usefulness of CO/1408 to ameliorate the symptoms observed in some obstructive pulmonary diseases." 04/01/1994 - "The present data indicate the ability of CO 1408 to modulate smoke-induced airway hyperreactivity and, to some extent, lung inflammation, an effect which might be of value in the therapy of obstructive pulmonary diseases."
2.	Pneumonia (Pneumonitis) 04/01/1994 - "We have investigated the effect of a new mucoactive compound, CO 1408, on airway hyperreactivity and lung inflammation induced in guinea-pigs by passive cigarette smoke exposure. " 04/01/1994 - "The present data indicate the ability of CO 1408 to modulate smoke-induced airway hyperreactivity and, to some extent, lung inflammation, an effect which might be of value in the therapy of obstructive pulmonary diseases."
3.	Inflammation (Inflammations) 04/01/1994 - "Effect of a mucoactive compound (CO 1408) on airway hyperreactivity and inflammation induced by passive cigarette smoke exposure in guinea-pigs."

Related Drugs and Biologics

1.	Smoke

Related Therapies and Procedures

1.	Therapeutics